About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Five medications have been approved for use in patients with Alzheimer’s disease; nonetheless, there remains an urgent need for new and effective drugs. This article describes the role of these agents, with an emphasis on their efficacy, effectiveness, costs, and associated controversies.
David A. Casey, MD, Demetra Antimisiaris, PharmD, and James O’Brien, MD
Hospital administrators are beginning to focus on bar-code scanning as a part of a multi-pronged strategy to reduce medication errors. The experience with bar-coding technology at four medical institutions is described.
Cindy H. Dubin
Caveat Emptor! (and Other Advice from Cyberspace)
The decades-old debate over generic versus brand-name drugs, once mainly the stuff of medical journals, is now a hot topic on the blogosphere as well. The author provides a sampling of postings from bloggers.
Topics include liraglutide injection (Victoza) for type-2 diabetes; Prevnar 13 vaccine for protection against invasive pneumococcal diseases in children; and olmesartan medoxomil (Benicar) for children with elevated blood pressure.
Marvin M. Goldenberg, PhD, RPh, MS
Continuing Education Credit
Clinical Considerations for the Health System Pharmacist
Targeted therapies are improving outcomes in patients with colorectal, non–small-cell lung cancer, and pancreatic cancer. The authors evaluate the efficacy of these agents and suggest strategies for preventing and managing adverse effects from these treatments to ensure optimal patient care.
Dwight D. Kloth, PharmD, FCCP, BCOP; Lew Iacovelli, BS, PharmD, BCOP, CPP; Rebecca Arbuckle, MS, RPh; and Angela C. McIntosh, PhD
David B. Nash, MD, MBA, discusses the importance of engaging patients in their own health care.
David B. Nash, MD, MBA
Matthew Grissinger, RPh, FASCP, explains the value of rapid response teams in hospitals for facilitating patient safety and communication.
Matthew Grissinger, RPh, FASCP
Meeting Criteria for Pharmacy Software and Electronic Medical Records Will Be Difficult
Stephen Barlas reviews the challenges facing hospitals as they begin to try to meet the basic definition of “meaningful use” and adopt electronic medical records.
From Exalgo to VPRIV, P&T presents the latest information about FDA approvals, drug indications, product recalls, and industry updates.
A Novel Therapeutic Agent, or a ‘Me-Too’ Drug?
Pitavastatin (Livalo), a statin for hyperlipidemia and mixed dyslipidemia, is reviewed.
Timothy Reilly, PharmD, BCPS; George King; Jee Hye Park; and Amanda Tracy